GI Genius™ is the first-to-market, deep learning, computer-aided polyp detection system, able to detect polyps of different shapes, sizes and morphologies in real time.
The first U.S. Trial using GI genius™ intelligent endoscopy module showed 50% reduction in missed colorectal polyps with artificial intelligence (AI) technology versus standard colonoscopy.
GI Genius™ increases ADR1 (adenoma detection rate) and decreases AMR2 (adenoma miss rate) as compared to standard of care.
1Repici A, Badalamenti M, Maselli R, et al. Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial. Gastroenterology. 2020; 159:512–520.e7
2DETECT study (clinicialtrials.gov identification number: NCT03954548)
The device is already approved in Europe (it is a CE-marked medical device) and in April 2021 GI Genius™ was approved by the FDA.
It is the first-to-market, deep learning, computer-aided polyp detection system which can be seamlessly integrated and is compatible with all major brands of endoscopic processors.
Global AI partnership with Medtronic
The device is developed by Cosmo Intelligent Medical Devices, a fully owned subsidiary of Cosmo Pharmaceuticals, and it is marketed worldwide by Medtronic, the global leader in medical technology.
In March 2023, Cosmo Intelligent Medical Devices expanded the cooperation with Medtronic to accelerate the development of Artificial Intelligence (AI) in the healthcare system and bring new AI-based solutions into patient care.
To know more about GI Genius™ and our vision for Artificial Intelligence, visit our dedicated website:
